在中国重症监护病房使用幽门后管饲预防呼吸机相关性肺炎(VIP研究):随机对照试验的研究方案
VIP研究是一项多中心、开放标签、随机对照试验,计划纳入924例预计机械通气不少于48小时的受试者,按1:1随机接受幽门后管饲或胃管管饲并同时采取常规预防措施。主要结局为至少发生一次呼吸机相关性肺炎的患者比例,试验旨在评估幽门后管饲对比胃管管饲的疗效与安全性。
要点
- 多中心、开放标签、随机对照试验,计划纳入924例预计机械通气不少于48小时的受试者。
- 受试者按1:1随机接受幽门后管饲或胃管管饲,同时采取常规预防措施。
- 主要结局为至少发生一次呼吸机相关性肺炎的患者比例。
核心结论
- 该试验旨在评估幽门后管饲对比胃管管饲在预防呼吸机相关性肺炎方面的疗效与安全性。
研究设计与样本
- 多中心、开放标签、随机对照试验,计划招募924例预计接受机械通气不少于48小时的受试者,按1:1随机分组。
关键数值与推荐
- 主要结局为至少发生一次呼吸机相关性肺炎的患者比例。
- 将密切观察不良事件和严重不良事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ventilator-associated pneumonia is a challenge in critical care and is associated with high mortality and morbidity. Although some consensuses on preventing ventilator-associated pneumonia are reached, it is still somewhat controversial. Meta-analysis has shown that postpyloric tube feeding may reduce the incidences of ventilator-associated pneumonia, which still desires high-quality evidence. This trial aims to evaluate the efficacy and safety profiles of postpyloric tube feeding versus gastric tube feeding. METHODS/DESIGN: In this multicenter, open-label, randomized controlled trial, we will recruit 924 subjects expected to receive mechanical ventilation for no less than 48 h. Subjects on mechanical ventilation will be randomized (1:1) to receive postpyloric or gastric tube feeding and routine preventive measures simultaneously. The primary outcome is the proportion of patients with at least one ventilator-associated pneumonia episode. Adverse events and serious adverse events will be observed closely. DISCUSSION: The VIP study is a large-sample-sized, multicenter, open-label, randomized, parallel-group, controlled trial of postpyloric tube feeding in China and is well-designed based on previous studies. The results of this trial may help to provide evidence-based recommendations for the prevention of ventilator-associated pneumonia. TRIAL REGISTRATION: Chictr.org.cn ChiCTR2100051593 . Registered on 28 September 2021.
引用
- Hu L, Peng K, Huang X, et al. Ventilator-associated pneumonia prevention in the Intensive care unit using Postpyloric tube feeding in China (VIP study): study protocol for a randomized controlled trial. Trials. 2022. PMID: 35681155. doi:10.1186/s13063-022-06407-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。